Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
You have to log in or sign up before you can proceed.
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: Schaeffler off to a good start in 2024: https://upload.wikimedia.org/wikipedia/commons/thumb/7/72/Schaeffler_logo.svg/640px-Schaeffler_logo.svg.png
EQS-News: Schaeffler off to a good start in 2024
EQS-News: Schaeffler off to a good start in 2024
eqs_en 
0 07.05.24
EQS-News: Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere.
EQS-News: Redcare Pharmacy's eHealth-CardLink solution has just been launched: the convenient way to redeem e-prescriptions from anywhere.
eqs_en 
0 06.05.24
EQS-News: Krones continues profitable growth path: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23725/Krones_Logo.svg.png
EQS-News: Krones continues profitable growth path
EQS-News: Krones continues profitable growth path
eqs_en 
0 03.05.24
EQS-News: ORDINARY ANNUAL GENERAL MEETING OF GRENKE AG APPROVES ALL AGENDA ITEMS : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg
EQS-News: ORDINARY ANNUAL GENERAL MEETING OF GRENKE AG APPROVES ALL AGENDA ITEMS
EQS-News: ORDINARY ANNUAL GENERAL MEETING OF GRENKE AG APPROVES ALL AGENDA ITEMS
eqs_en 
0 30.04.24
EQS-News: Fielmann Group with +12% sales growth in 2023 and +11% growth in Q1/2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23710/Fielmann-Logo.svg.png
EQS-News: Fielmann Group with +12% sales growth in 2023 and +11% growth in Q1/2024
EQS-News: Fielmann Group with +12% sales growth in 2023 and +11% growth in Q1/2024
eqs_en 
0 30.04.24
EQS-News: MorphoSys AG Reports First Quarter 2024 Financial Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys AG Reports First Quarter 2024 Financial Results
EQS-News: MorphoSys AG Reports First Quarter 2024 Financial Results
eqs_en 
0 29.04.24
EQS-News: Annual General Meeting of Schaeffler approves merger ofVitesco Technologies Group Aktiengesellschaft into Schaeffler AG: https://upload.wikimedia.org/wikipedia/commons/thumb/7/72/Schaeffler_logo.svg/640px-Schaeffler_logo.svg.png
EQS-News: Annual General Meeting of Schaeffler approves merger ofVitesco Technologies Group Aktiengesellschaft into Schaeffler AG
EQS-News: Annual General Meeting of Schaeffler approves merger ofVitesco Technologies Group Aktiengesellschaft into Schaeffler AG
eqs_en 
0 25.04.24
EQS-News: Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany.
EQS-News: Redcare’s fast double-digit growth continues in Q1, and at a 2.1% positive margin. Also in Q1, after many years, breakthrough in online e-Rx in Germany.
eqs_en 
0 25.04.24
EQS-News: MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
EQS-News: MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
eqs_en 
0 24.04.24
EQS-News: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
EQS-News: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
eqs_en 
0 23.04.24
EQS-Adhoc: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-Adhoc: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
EQS-Adhoc: Redcare Pharmacy’s eHealth-CardLink solution approved by gematik today.
eqs_en 
0 23.04.24
EQS-News: Artificial intelligence: Schaeffler and Siemens intensify collaboration: https://upload.wikimedia.org/wikipedia/commons/thumb/7/72/Schaeffler_logo.svg/640px-Schaeffler_logo.svg.png
EQS-News: Artificial intelligence: Schaeffler and Siemens intensify collaboration
EQS-News: Artificial intelligence: Schaeffler and Siemens intensify collaboration
eqs_en 
0 22.04.24
EQS-News: Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.
EQS-News: Redcare Pharmacy's Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.
eqs_en 
0 18.04.24
EQS-News: Nagarro releases audited results for 2023 - annual revenue grew 9.4% in constant currency: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-News: Nagarro releases audited results for 2023 - annual revenue grew 9.4% in constant currency
EQS-News: Nagarro releases audited results for 2023 - annual revenue grew 9.4% in constant currency
eqs_en 
0 16.04.24
EQS-News: MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
EQS-News: MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
eqs_en 
0 11.04.24
EQS-News: GRENKE starts year with a strong Contribution Margin 2 in Q1 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg
EQS-News: GRENKE starts year with a strong Contribution Margin 2 in Q1 2024
EQS-News: GRENKE starts year with a strong Contribution Margin 2 in Q1 2024
eqs_en 
0 04.04.24
EQS-News: Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.: https://upload.wikimedia.org/wikipedia/commons/thumb/0/07/Shop_Apotheke_Europe_logo.svg/640px-Shop_Apotheke_Europe_logo.svg.png
EQS-News: Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.
EQS-News: Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.
eqs_en 
0 04.04.24
EQS-News: Krones successfully completes acquisition of injection molding technology company Netstal : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23725/Krones_Logo.svg.png
EQS-News: Krones successfully completes acquisition of injection molding technology company Netstal
EQS-News: Krones successfully completes acquisition of injection molding technology company Netstal
eqs_en 
0 28.03.24
EQS-News: CANCOM SE: CANCOM publishes Annual Report 2023 and forecasts significant growth: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png
EQS-News: CANCOM SE: CANCOM publishes Annual Report 2023 and forecasts significant growth
EQS-News: CANCOM SE: CANCOM publishes Annual Report 2023 and forecasts significant growth
eqs_en 
0 28.03.24
EQS-News: Krones plans to pay dividend of €2.20 per share for successful 2023 financial year: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23725/Krones_Logo.svg.png
EQS-News: Krones plans to pay dividend of €2.20 per share for successful 2023 financial year
EQS-News: Krones plans to pay dividend of €2.20 per share for successful 2023 financial year
eqs_en 
0 22.03.24
EQS-News: Schaeffler AG successfully places a bond in the amount of 850 million euros: https://upload.wikimedia.org/wikipedia/commons/thumb/7/72/Schaeffler_logo.svg/640px-Schaeffler_logo.svg.png
EQS-News: Schaeffler AG successfully places a bond in the amount of 850 million euros
EQS-News: Schaeffler AG successfully places a bond in the amount of 850 million euros
eqs_en 
0 22.03.24
EQS-News: MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
EQS-News: MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
eqs_en 
0 22.03.24
EQS-News: PATRIZIA Annual Report 2023: Resilient platform but EBITDA impacted by market headwinds - cautious optimism for 2024 with focus on smart real asset investments: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24117/375px-Logo_Patrizia_Immobilien_AG.svg.png
EQS-News: PATRIZIA Annual Report 2023: Resilient platform but EBITDA impacted by market headwinds - cautious optimism for 2024 with focus on smart real asset investments
EQS-News: PATRIZIA Annual Report 2023: Resilient platform but EBITDA impacted by market headwinds - cautious optimism for 2024 with focus on smart real asset investments
eqs_en 
0 21.03.24
EQS-News: 1&1 with successful fiscal year 2023 : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png
EQS-News: 1&1 with successful fiscal year 2023
EQS-News: 1&1 with successful fiscal year 2023
eqs_en 
0 21.03.24
EQS-News: Dr Konstantin Mettenheimer to not stand for re-election to the GRENKE AG Supervisory Board at the Annual General Meeting on April 30, 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg
EQS-News: Dr Konstantin Mettenheimer to not stand for re-election to the GRENKE AG Supervisory Board at the Annual General Meeting on April 30, 2024
EQS-News: Dr Konstantin Mettenheimer to not stand for re-election to the GRENKE AG Supervisory Board at the Annual General Meeting on April 30, 2024
eqs_en 
0 15.03.24